跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 171 条关于
“GL CHEMTEC”
全部
171
临床试验
69
药物
70
机构
11
资讯
21
去年
GL CHEMTEC Completes State-of-the-Art GMP Facility to Accelerate Clinical Trial Material Production
9个月前
Agora Open Science Trust Selects M4K2009 as Lead Candidate for Rare Pediatric Brain Cancer Treatment
去年
Genetic Leap Receives FDA IND Clearance for First-in-Class Oral IL-2 Modulator GL-IL2-138
去年
UWM-Developed Drug, GL-Damonia, Enters FDA Phase 1 Trials for Depression and Alzheimer's
去年
Regeneron Appeals Eylea Biosimilar Ruling; Prime Therapeutics Adds Humira Biosimilars; Denosumab Biosimilar Advances
4个月前
LTZ Therapeutics Secures $38 Million to Advance Universal Myeloid Cell Engager Immunotherapy Platform
去年
EMA Accepts Alvotech's Biosimilar AVT03 for Prolia and Xgeva
2年前
EMA Approves First Ustekinumab Biosimilar, Uzpruvo, for Inflammatory Conditions
7个月前
Alvotech Reports Positive Results for Entyvio Biosimilar in Pivotal Pharmacokinetic Study
去年
CDSCO Panel Approves Label Updates for Sanofi's Rare Disease Therapies Fabrazyme and Aldurazyme
第 1 页,共 3 页
上一页
下一页